|3Feb 4, 8:25 PM ET

Eclipse GP III, LLC 3

3 · Lucira Health, Inc. · Filed Feb 4, 2021

Insider Transaction Report

Form 3
Period: 2021-02-04
Holdings
  • Series A Preferred Stock

    (indirect: See footnote)
    Common Stock (976,852 underlying)
  • Series B Preferred Stock

    (indirect: See footnote)
    Common Stock (877,445 underlying)
  • Series C Preferred Stock

    (indirect: See footnote)
    Common Stock (185,512 underlying)
  • Series C Preferred Stock

    Common Stock (3,710,257 underlying)
  • Convertible Promissory Note

    Exercise: $13.60Exp: 2022-12-11Common Stock (473,729 underlying)
Footnotes (4)
  • [F1]Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (the "Preferred Stock") automatically converts on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
  • [F2]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
  • [F3]The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.
  • [F4]The convertible promissory note will automatically convert into shares of the Issuer's Common Stock upon the closing of the IPO.

Documents

1 file
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION